Trial
NCT00312754
A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
HIV Infections
Intervention
Atazanavir
Why stopped
insufficient enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-19